NEAL KLEIMAN to Adult
This is a "connection" page, showing publications NEAL KLEIMAN has written about Adult.
Connection Strength
0.261
-
Should Interventional Cardiologists Super-Subspecialize?: Moving From Patient Selection to Operator Selection. JACC Cardiovasc Interv. 2021 01 11; 14(1):97-100.
Score: 0.031
-
Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. J Thromb Thrombolysis. 2012 Feb; 33(2):137-42.
Score: 0.016
-
Stent-assisted coil embolization of a large fusiform aneurysm of proximal anterior descending artery: novel treatment for coronary aneurysms. Circ Cardiovasc Interv. 2012 Feb 01; 5(1):e3-5.
Score: 0.016
-
Balancing hemostasis and thrombosis in interventional vascular medicine and surgery. Methodist Debakey Cardiovasc J. 2011 Oct-Dec; 7(4):19-23.
Score: 0.016
-
Determinants of plasma vitamin D levels in patients with acute coronary syndromes. Eur J Clin Invest. 2011 Dec; 41(12):1299-309.
Score: 0.016
-
Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Thromb Haemost. 2008 Jul; 100(1):83-9.
Score: 0.013
-
Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease. Am Heart J. 2007 Oct; 154(4):694.e1-7.
Score: 0.012
-
Platelet reactivity among Asian Indians and Caucasians. Platelets. 2007 Jun; 18(4):261-5.
Score: 0.012
-
Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. Am Heart J. 2007 Jan; 153(1):41.e1-6.
Score: 0.012
-
Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects. Am J Cardiol. 2007 Jan 01; 99(1):124-8.
Score: 0.011
-
Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. Thromb Res. 2003; 111(3):171-7.
Score: 0.009
-
Cardiac Arrest in Young Adults With Ischemic Heart Disease in the United States, 2004-2018. Curr Probl Cardiol. 2022 Nov; 47(11):101312.
Score: 0.008
-
Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide. Am Heart J. 2002 Apr; 143(4):585-93.
Score: 0.008
-
National Trends and Outcomes of Surgical Aortic Valve Replacement With Concomitant Mitral Valve Surgery. Cardiovasc Revasc Med. 2022 07; 40:13-19.
Score: 0.008
-
Trends in Outcomes of Hospitalized Adults Undergoing Percutaneous Balloon Mitral Valvuloplasty in the United States. Cardiovasc Revasc Med. 2022 06; 39:117-120.
Score: 0.008
-
First in Man Pilot Feasibility Study in Extracranial Carotid Robotic-Assisted Endovascular Intervention. Neurosurgery. 2021 02 16; 88(3):506-514.
Score: 0.008
-
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial. Heart Rhythm. 2021 07; 18(7):1045-1054.
Score: 0.008
-
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study. Circ Res. 2018 04 13; 122(8):1109-1118.
Score: 0.006
-
Case report: It wasn't cupid: multimodality imaging of inferior vena cava filter fracture with strut migration to the interventricular septum. Methodist Debakey Cardiovasc J. 2014 Jul-Sep; 10(3):198-200.
Score: 0.005
-
Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. J Thromb Thrombolysis. 2012 Jul; 34(1):91-8.
Score: 0.004
-
Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv. 2012 Nov 01; 80(5):717-25.
Score: 0.004
-
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010 Sep; 3(9):920-7.
Score: 0.004
-
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010 Aug; 3(4):327-34.
Score: 0.004
-
Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. J Thromb Thrombolysis. 2010 Jan; 29(1):60-9.
Score: 0.004
-
Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. Am Heart J. 2008 Nov; 156(5):1002.e1-1002.e7.
Score: 0.003
-
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J. 2007 May; 153(5):874-80.
Score: 0.003
-
Idiopathic sinus of Valsalva to right atrial fistula: an unusual origin of right-sided heart failure. J Am Soc Echocardiogr. 2004 Dec; 17(12):1317-8.
Score: 0.003
-
Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variability. Clin Pharmacol Ther. 2004 Jan; 75(1):60-9.
Score: 0.002
-
Simultaneous modeling of abciximab plasma concentrations and ex vivo pharmacodynamics in patients undergoing coronary angioplasty. J Pharmacol Exp Ther. 2003 Dec; 307(3):969-76.
Score: 0.002
-
Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects. Clin Pharmacol Ther. 2002 Mar; 71(3):186-95.
Score: 0.002
-
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002 Feb 19; 105(7):788-93.
Score: 0.002